Alan P Lombard
7PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 05, 2025
IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate Cancer.Amy R Leslie, Shu Ning, Masuda Sharifi
|Oct 23, 2024
PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells.Zachary A Schaaf, Shu Ning, Amy R Leslie
|Aug 01, 2024
LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy.Shu Ning, Cameron M Armstrong, Enming Xing
|Aug 05, 2022
Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment.Shu Ning, Chengfei Liu, Wei Lou
|Jan 28, 2022
Olaparib-Induced Senescence Is Bypassed through G2-M Checkpoint Override in Olaparib-Resistant Prostate Cancer.Alan P Lombard, Cameron M Armstrong, Leandro S D'Abronzo
Pageof 2
Frequent Collaborators
7 joint publications
Shu Ning
6 joint publications
Chengfei Liu
6 joint publications
Wei Lou
6 joint publications
Amy R Leslie
6 joint publications
Masuda Sharifi
6 joint publications
Allen C Gao
5 joint publications
Zachary A Schaaf
4 joint publications
Richard Y Gao
4 joint publications
James P Maine
3 joint publications
Pui-Kai Li
